These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 35352535)
1. Perspectives on the urological care in Parkinson's disease patients. Moussa M; Abou Chakra M; Papatsoris AG; Dellis A; Dabboucy B; Peyromaure M; Barry Delongchamps N; Bailly H; Duquesne I Arch Ital Urol Androl; 2022 Mar; 94(1):107-117. PubMed ID: 35352535 [TBL] [Abstract][Full Text] [Related]
2. A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders. Sakakibara R; Panicker J; Finazzi-Agro E; Iacovelli V; Bruschini H; Neurourol Urodyn; 2016 Jun; 35(5):551-63. PubMed ID: 25810035 [TBL] [Abstract][Full Text] [Related]
3. Clinical study of the effects of deep brain stimulation on urinary dysfunctions in patients with Parkinson's disease. Zong H; Meng F; Zhang Y; Wei G; Zhao H Clin Interv Aging; 2019; 14():1159-1166. PubMed ID: 31417246 [No Abstract] [Full Text] [Related]
5. Therapeutic efficacy of low-dose (25 mg) mirabegron therapy for patients with mild to moderate overactive bladder symptoms due to central nervous system diseases. Chen SF; Kuo HC Low Urin Tract Symptoms; 2019 Apr; 11(2):O53-O58. PubMed ID: 29380517 [TBL] [Abstract][Full Text] [Related]
6. Underactive and overactive bladders are related to motor function and quality of life in Parkinson's disease. Liu Z; Uchiyama T; Sakakibara R; Yamamoto T Int Urol Nephrol; 2015 May; 47(5):751-7. PubMed ID: 25792006 [TBL] [Abstract][Full Text] [Related]
7. Urinary tract dysfunction in Parkinson's disease: a review. Yeo L; Singh R; Gundeti M; Barua JM; Masood J Int Urol Nephrol; 2012 Apr; 44(2):415-24. PubMed ID: 21553114 [TBL] [Abstract][Full Text] [Related]
8. A review of lower urinary tract symptoms in patients with Parkinson's disease. Badri AV; Purohit RS; Skenazy J; Weiss JP; Blaivas JG Curr Urol Rep; 2014 Sep; 15(9):435. PubMed ID: 25002072 [TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy. Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298 [TBL] [Abstract][Full Text] [Related]
11. [Cognitive adverse effects of anticholinergic medication for overactive bladder in PD/DLB]. Sakakibara R Rinsho Shinkeigaku; 2013; 53(11):1389-92. PubMed ID: 24292000 [TBL] [Abstract][Full Text] [Related]
12. Assessment and Management of Urinary Dysfunction in 187 Patients with Parkinson's Disease. Jia C; Cui X; Yoshimura N; Mao W; Xu E; Wang Q; Ou T J Parkinsons Dis; 2020; 10(3):993-1001. PubMed ID: 32310185 [TBL] [Abstract][Full Text] [Related]
13. Lower Urinary Tract Symptoms: What's New in Medical Treatment? Peyronnet B; Brucker BM; Michel MC Eur Urol Focus; 2018 Jan; 4(1):17-24. PubMed ID: 29665997 [TBL] [Abstract][Full Text] [Related]
14. The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease. Kabay S; Canbaz Kabay S; Cetiner M; Mestan E; Sevim M; Ayas S; Ozden H; Ozisik Karaman H Urology; 2016 Jan; 87():76-81. PubMed ID: 26436213 [TBL] [Abstract][Full Text] [Related]
15. Effects of dopaminergic treatment on bladder function in Parkinson's disease. Winge K; Werdelin LM; Nielsen KK; Stimpel H Neurourol Urodyn; 2004; 23(7):689-96. PubMed ID: 15382192 [TBL] [Abstract][Full Text] [Related]
16. The efficacy and tolerability of the β3-adrenoceptor agonist mirabegron for the treatment of symptoms of overactive bladder in older patients. Wagg A; Cardozo L; Nitti VW; Castro-Diaz D; Auerbach S; Blauwet MB; Siddiqui E Age Ageing; 2014 Sep; 43(5):666-75. PubMed ID: 24610862 [TBL] [Abstract][Full Text] [Related]
17. [Intradetrusor injections of botulinum toxin A to treat urinary incontinence due to bladder overactivity during idiopathic Parkinson's disease]. Atamian A; Sichez PC; Michel F; Bandelier Q; Fall M; Gaillet S; Azoulay JP; Lechevallier E; Karsenty G Prog Urol; 2021 Jun; 31(7):430-438. PubMed ID: 33579624 [TBL] [Abstract][Full Text] [Related]
18. Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment. Palleschi G; Pastore AL; Stocchi F; Bova G; Inghilleri M; Sigala S; Carbone A Clin Neuropharmacol; 2006; 29(4):220-9. PubMed ID: 16855424 [TBL] [Abstract][Full Text] [Related]